Skip to main content
Springer logoLink to Springer
. 2022 Oct 13;38(5):1559–1568. doi: 10.1007/s00467-022-05760-6

Health-related quality of life in adults after pediatric kidney failure in Switzerland

Marc-Andrea Heinzelmann 1,, Claudia E Kuehni 1,2, Katharina Roser 3, Luzius Mader 4,#, Guido F Laube 5,#; on behalf of the Swiss Pediatric Renal Registry (SPRR) group
PMCID: PMC10060264  PMID: 36227439

Abstract

Background

Little is known about health-related quality of life (HRQoL) in adults after kidney failure during childhood. In this study, we analyzed HRQoL of adults after pediatric kidney failure in Switzerland and investigated socio-demographic and clinical factors associated with HRQoL.

Methods

In this cohort study, we sent questionnaires to 143 eligible patients registered in the Swiss Pediatric Renal Registry with continuous kidney replacement therapy starting before the age of 18 years. We assessed HRQoL using the Short-Form 36 version 1, compared HRQoL scores between our sample and the Swiss general population, and used linear regression models to examine socio-demographic and clinical factors associated with HRQoL.

Results

We included 79 patients (response rate 55%) with a mean age of 38.6 years (range 19.4–63.1). Compared to the general population, HRQoL scores were lower for physical functioning (− 12.43, p < 0.001), role physical (− 13.85, p = 0.001), general health (− 14.42, p < 0.001), vitality (− 4.98, p = 0.035), and physical HRQoL (− 6.11, p < 0.001), but we found no difference in mental HRQoL (− 0.13, p = 0.932). The socio-demographic factors—lower education, unemployment, and not being in a relationship—were associated with lower HRQoL. The only clinical factor associated with HRQoL was the type of kidney disease. Patients with acquired kidney diseases had lower mental HRQoL than patients with congenital anomalies of the kidney and urinary tract (− 11.4, p = 0.007) or monogenetic hereditary diseases (− 9.5, p = 0.018).

Conclusions

Adults after pediatric kidney failure in Switzerland have lower physical, but similar mental HRQoL compared to the general population. Subgroups may require special attention with regard to their HRQoL.

Graphical abstract

graphic file with name 467_2022_5760_Figa_HTML.jpg

A higher resolution version of the Graphical abstract is available as Supplementary information

Supplementary Information

The online version contains supplementary material available at 10.1007/s00467-022-05760-6.

Keywords: Health-related quality of life, Pediatric kidney failure, Kidney replacement therapy, Short-Form 36

Introduction

Chronic kidney disease followed by kidney failure (KF) is rare in childhood. It is treated by kidney replacement therapy (KRT), including kidney transplantation, hemodialysis, or peritoneal dialysis. Patient and graft survival after pediatric kidney transplantation have steadily improved over the last decades [1, 2]. KF during childhood is associated with various long-term complications, such as cardiovascular disease, secondary malignancies, growth retardation, or side effects of long-lasting treatments (e.g., infections after immunosuppression) [3]. Psycho-social outcomes such as health-related quality of life (HRQoL), educational achievement, employment situation, civil status, and living arrangements can also be affected. In patients with adult-onset KF, HRQoL has become a crucial outcome parameter and lower HRQoL has been shown to be associated with a higher risk of death and hospitalizations [4].

Children after kidney transplantation reported HRQoL comparable to healthy children, although the parents indicated impaired HRQoL for their children [5]. HRQoL in adults after pediatric KF has rarely been examined. Studies that did not use standardized questionnaire instruments reported a good or even excellent quality of life [68]. However, HRQoL was rated poorer in comparison to the general population when standardized questionnaire instruments were used [912]. In this study, we aimed to describe HRQoL of adults who started receiving continuous KRT before the age of 18 years in Switzerland and investigate socio-demographic and clinical factors associated with HRQoL.

Methods

Study population

Patients were recruited from the Swiss Pediatric Renal Registry (SPRR), which had been established during the 1970s to gather data about children with KF in Switzerland [13]. We defined the following inclusion criteria for our study: (1) continuous KRT before the age of 18 years (kidney transplantation before the age of 18 years or start of dialysis before the age of 18 years followed by a kidney transplantation after the age of 18 years), (2) aged ≥ 18 years at study, (3) alive, and (4) formerly treated in a German-speaking children’s hospital in Switzerland. We decided to focus on the language region with the largest number of patients, for feasibility reasons in this unfunded study.

Study design

This was a cross-sectional study nested in the longitudinal SPRR. We developed a questionnaire to assess a range of long-term outcomes in adults after pediatric KF with subsequent continuous KRT. The questionnaire was based on one we had used in a pilot study and the questionnaire of the Swiss Childhood Cancer Survivor Study [14], which assessed similar long-term outcomes. The questionnaire included items about the kidney disease, undergone treatments, comorbidities, current medications, education, profession, living arrangement, and lifestyle. We also included the Short-Form 36 (SF-36) version 1 as a standardized instrument for the evaluation of HRQoL [15]. We updated postal addresses of eligible patients via the national postal service and by contacting the hospitals the patients were transferred to after leaving pediatric care. Eligible patients had the option to either complete the questionnaire online or on paper. We sent two reminder letters with an additional copy of the questionnaire to all non-responders 1 and 2 months after initial contact, respectively.

Evaluation of health-related quality of life

HRQoL was evaluated with the SF-36. It is one of the most extensively used questionnaire instruments to evaluate HRQoL and includes 36 items [16]. The SF-36 uses 35 out of 36 items to generate eight different subscales. Each item is exclusive to one subscale. The following eight subscales are defined: physical functioning (PF, 10 items), role physical (RP, 4 items), bodily pain (BP, 2 items), general health (GH, 5 items), vitality (VT, 4 items), social functioning (SF, 2 items), role emotional (RE, 3 items), and mental health (MH, 5 items). Higher subscale scores are indicative of a better health state (e.g. high scores for the subscale bodily pain imply absence of bodily pain) [15, 17]. The two summary scales, physical component summary (PCS) and mental component summary (MCS), are norm-based and weighted sums of the eight subscale scores [18]. PCS represents self-reported physical HRQoL and MCS self-reported mental HRQoL. Higher PCS and MCS scores represent better physical and mental HRQoL, respectively. The four subscales PF, RP, BP, and GH correlate primarily with PCS, whereas VT, SF, RE, and MH correlate mainly with MCS [18]. We compared our SF-36 version 1 scores to normative data from the general population of Switzerland for the SF-36 version 2 that were recently published [16]. Since standardized scoring is used, a direct comparison of results is possible [19].

Socio-demographic and clinical variables

We assessed the following socio-demographic variables: age (continuous), gender (male, female), education (compulsory schooling or vocational training, upper secondary or university education) [20], employment status (employed or studying, unemployed), relationship status (in a relationship, not in a relationship), and living arrangement (living alone, not living alone).

Additionally, we investigated the following clinical variables obtained from the SPRR: type of kidney disease categorized into (1) congenital anomalies of the kidney and urinary tract (CAKUT), (2) monogenetic hereditary diseases, and (3) acquired diseases [13], age at first KRT (< 10 years, ≥ 10 years), and duration of KRT (< 25 years, ≥ 25 years). We assessed the type of KRT at time of study (dialysis, transplantation) and the number of transplants (1 transplant, > 1 transplant) in the questionnaire.

Statistical analysis

First, we described HRQoL in our sample. The data collected from the questionnaires were evaluated according to the manuals for the SF-36 [15, 18]. Raw subscale scores are the sum of the items from the respective subscale. Missing raw subscale scores were calculated using the mean value, if at least half of the items for the respective scale were completed [15]. After raw subscale scores were calculated, they were transformed to a 0 to 100 scale, the so-called transformed scores. We used means and standard deviations from the Swiss general population as well as the transformed scores to generate a standardized score of every subscale. Then, we summed up standardized subscale scores using the corresponding factor score coefficients as weights to generate the PCS and MCS [16, 18]. Second, we compared the eight transformed subscale scores, PCS and MCS, to normative data from the Swiss general population using linear regression models adjusted for age and gender [16]. Third, we used linear regression models adjusted for age and gender to investigate socio-demographic and clinical variables associated with subscale scores, PCS and MCS. We performed all statistical analyses using Stata 16 (StataCorp LP, College Station, TX).

Results

Participants and their characteristics

Out of 166 eligible patients for the study, we contacted 143 with the questionnaire (Fig. 1). Of those, 79 (55%) completed the questionnaire and were included in the analysis. One-third (34%) completed the survey online and 66% on paper. Socio-demographic and clinical characteristics of the participants are shown in Table 1. Mean age at study was 38.6 years (range: 19.4–63.1). Slightly more than half of the participants were male (57%). Almost half of participants (44%) had achieved upper secondary or university education. More than two-thirds of patients were employed or studying (76%) and 46% reported to be in a relationship. All patients had been transplanted. While a small number of patients (11%) had up to three kidney transplants and one-third (33%) had two transplants, most patients (56%) have had one transplant. The majority of participants (83%) reported having a functioning transplant at time of study. No differences were found between participants and non-participants for age, gender, type of kidney disease, age at start of KRT, and mean duration of KRT (all p > 0.05) (Online Resource 1).

Fig. 1.

Fig. 1

Flowchart of the study population

Table 1.

Characteristics of the participants

(n = 79) % of total
Mean age at time of study in years (range) 38.6 (19.4–63.1)
Gender
     Female 34 43%
      Male 45 57%
Education
     Compulsory schooling or vocational training 41 52%
     Upper secondary or university education 35 44%
      Missing 3 4%
Employment status
       Employed or studying 60 76%
       Unemployed 19 24%
Relationship status
         In a relationship 36 46%
         Not in a relationship 42 53%
         Missing 1 1%
Living arrangement
         Living alone 26 33%
         Not living alone 53 67%
Type of kidney disease
        Congenital anomalies of the kidney and urinary tract 29 37%
         Monogenetic hereditary diseases 34 43%
          Acquired diseases 16 20%
Age at first KRT
          Mean age at first KRT in years (range) 10.2 (0.0–17.9)
          < 10 years 32 41%
          ≥ 10 years 47 59%
Duration of KRT
         Mean duration of KRT in years (range) 28.4 (10.5–48.7)
         < 25 years 31 39%
         ≥ 25 years 48 61%
Type of KRT at time of study
        Transplantation 66 83%
        Dialysis 10 13%
        Missing 3 4%
Number of transplants
      1 transplant 44 56%
      2 transplants 26 33%
      3 transplants 9 11%

Abbreviations: KRT kidney replacement therapy

SF-36 scores and comparison to the Swiss general population

Mean SF-36 subscale scores, PCS and MCS, of our study population and the Swiss general population are presented in Table 2. After adjusting for age and gender, we observed lower scores in the four subscales physical functioning (− 12.43, p < 0.001), role physical (− 13.85, p = 0.001), general health (− 14.42, p < 0.001), and vitality (− 4.98, p = 0.035) in our study population compared to the Swiss general population. No significant differences were found for the subscales bodily pain, social functioning, role emotional, or mental health (all p > 0.05). Our study population also showed a significantly lower PCS (− 6.11, p < 0.001), whereas we found no difference in MCS in comparison to the Swiss general population (− 0.13, p = 0.932).

Table 2.

Mean SF-36 scores of the study population compared to the Swiss general population

Study population mean (SD) (n = 79) Swiss general population mean (SD) (n = 1209) Adjusted differencea p value
SF-36 subscale scores (0–100)
    Physical functioning (PF) 81.58 (25.29) 91.16 (17.01)  − 12.43  < 0.001
     Role physical (RP) 75.66 (37.85) 86.41 (20.60)  − 13.85 0.001
     Bodily pain (BP) 83.59 (24.81) 74.58 (26.03) 4.92 0.089
     General health (GH) 62.98 (23.19) 75.64 (17.35)  − 14.42  < 0.001
     Vitality (VT) 57.53 (20.53) 63.24 (17.22)  − 4.98 0.035
     Social functioning (SF) 86.35 (20.43) 85.84 (20.02) 0.77 0.752
     Role emotional (RE) 82.89 (34.21) 87.64 (19.22)  − 4.53 0.252
     Mental health (MH) 74.91 (19.00) 75.02 (16.18) 0.61 0.781
SF-36 summary scales
     Physical component summary (PCS) 46.19 (14.02) 50 (10)  − 6.11  < 0.001
     Mental component summary (MCS) 48.76 (12.67) 50 (10)  − 0.13 0.932

Abbreviations: SD, standard deviation; SF-36, Short-Form 36

aAdjusted for age and gender

Associations between socio-demographic and clinical variables and SF-36 scores

Associations between socio-demographic and clinical variables and SF-36 scores are displayed in Tables 3 and 4. We found no association between age and gender with any of the SF-36 scores. Participants with compulsory schooling or vocational training scored lower on the subscales physical functioning (− 14.3, p = 0.007), role physical (− 17.4, p = 0.049), and vitality (− 11.9, p = 0.011) compared to those with upper secondary or university education. Unemployed participants scored lower on the subscales physical functioning (− 28.3, p < 0.001), role physical (− 26.9, p = 0.008), general health (− 19.9, p = 0.001), vitality (− 13.5, p = 0.012), and social functioning (− 19.6, p < 0.001) and had a lower PCS (− 12.9, p = 0.001) in comparison to participants who are employed or studying. Participants not in a relationship scored lower on the subscales physical functioning (− 17.7, p = 0.002) and general health (− 11.5, p = 0.031) and reported lower PCS (− 7.1, p = 0.029) compared to participants in a relationship. No associations between living arrangement and SF-36 scores were identified.

Table 3.

Differences between subscale scores and component summary scores based on socio-demographic variables using linear regression modelsa

Physical functioning
(95% CI)
Role
physical
(95% CI)
Bodily pain
(95% CI)
General health
(95% CI)
Vitality
(95% CI)
Social functioning
(95% CI)
Role emotional
(95% CI)
Mental health
(95% CI)
Physical component summary
(95% CI)
Mental component summary
(95% CI)
Age (years)

 − 0.5

(− 1.1, 0.1)

 − 0.5

(− 1.4, 0.4)

 − 0.4

(− 1.0, 0.2)

 − 0.1

(− 0.6, 0.4)

0.0

(− 0.4, 0.5)

0.0

(− 0.5, 0.4)

0.0

(− 0.8, 0.8)

0.0

(− 0.4, 0.5)

 − 0.3

(− 0.6, 0.1)

0.1

(–0.2, 0.4)

Gender
Male (ref)
Female

 − 1.8

(− 13.3, 9.6)

 − 4.1

(− 21.8, 13.6)

 − 5.9

(− 17.4, 5.6)

 − 3.6

(− 14.4, 7.2)

 − 9.0

(− 18.4, 0.4)

 − 3.3

(− 12.9, 6.3)

 − 11.1

(− 27.1, 4.9)

 − 7.0

(− 15.7, 1.8)

 − 0.6

(− 7.2, 6.1)

 − 4.5

(− 10.5, 1.5)

Education
Higherb (ref)
Lowerc

 − 14.3*

(− 24.7, − 4.0)

 − 17.4*

(− 34.7, − 0.1)

 − 8.5

(− 20.2, 3.2)

 − 8.9

(− 19.7, 1.9)

 − 11.9*

(− 21.0, − 2.8)

 − 7.7

(− 17.6, 2.1)

 − 10.1

(− 26.5, 6.2)

 − 5.9

(− 14.8, 3.0)

 − 6.1

(− 12.5, 0.2)

 − 4.0

(− 10.1, 2.1)

Employment status
Employed (ref)
Unemployed

 − 28.3**

(− 40.0, − 16.7)

 − 26.9*

(− 46.7, − 7.1)

 − 10.0

(− 23.0, 3.0)

 − 19.9*

(− 31,8, − 8.0)

 − 13.5*

(− 24.0, − 3.1)

 − 19.6**

(− 29.9, − 9.3)

 − 17.0

(− 35.3, 1.2)

 − 5.4

(− 15.5, 4.7)

 − 12.9*

(− 20.3, − 5.6)

 − 5.8

(− 13.0, 1.2)

Relationship status
In a relationship (ref)
Not in a relationship

 − 17.7*

(− 28.5, − 7.0)

 − 13.6

(− 31.1, 3.9)

 − 1.1

(− 12.6, 10.5)

11.5*

(− 22.0, − 1.1)

 − 3.4

(− 12.7, 6.0)

 − 2.9

(− 12.5, 6.6)

0.1

(− 16.0, 16.2)

 − 3.3

(− 12.1, 5.4)

 − 7.1*

(− 13.5, − 0.8)

0.2

(− 5.8, 6.2)

Living arrangement
Not living alone (ref)
Living alone

1.5

(− 10.6, 13.7)

8.8

(− 9.8, 27.4)

4.7

(− 7.5, 16.9)

0.0

(− 11.6, 11.5)

2.1

(− 7.8, 12.1)

2.3

(− 7.9, 12.6)

14.4

(− 2.2, 31.1)

 − 0.8

(− 10.1, 8.5)

2.4

(− 4.8, 9.5)

2.1

(− 4.4, 8.5)

Abbreviations: CI, confidence interval; ref, reference value

aAdjusted for age and gender

bUpper secondary or university education

cCompulsory schooling or vocational training

*p value < 0.05, **p value < 0.001

Table 4.

Differences between subscale scores and component summary scores based on clinical variables using linear regression modelsa

Physical functioning
(95% CI)
Role
physical
(95% CI)
Bodily pain
(95% CI)
General health
(95% CI)
Vitality
(95% CI)
Social functioning
(95% CI)
Role emotional
(95% CI)
Mental health
(95% CI)
Physical component summary
(95% CI)
Mental component summary
(95% CI)
Type of kidney disease
Acquired diseases (ref)
CAKUT

3.6

(− 12.8, 20.0)

4.8

(− 20.2, 29.8)

4.5

(− 11.8, 20.8)

5.9

(− 9.6, 21.4)

9.7

(− 3.4, 22.8)

13.1

(− 0.5, 26.7)

28.3*

(6.7, 49.9)

11.8

(− 0.4, 24.0)

 − 1.0

(− 10.5, 8.5)

11.4*

(3.2, 19.6)

Monogenetic hereditary diseases

3.1

(− 12.7, 18.9)

9.1

(− 15.0, 33.2)

6.7

(− 8.8, 22.2)

12.0

(− 3.0, 27.0)

11.7

(− 0.9, 24.2)

12.4

(− 0.6, 25.5)

23.2*

(2.4, 43.9)

6.7

(− 5.0, 18.4)

3.4

(− 5.7, 12.4)

9.5*

(1.7, 17.4)

Age at first KRT
 ≥ 10 years (ref)
 < 10 years

 − 6.8

(− 20.1, 6.6)

3.8

(− 16.7, 24.3)

4.8

(− 8.6, 18.2)

5.1

(− 7.5, 17.7)

1.6

(− 9.3, 12.5)

1.5

(− 9.7, 12.7)

4.6

(− 13.8, 22.9)

4.3

(− 5.9, 14.4)

 − 1.2

(− 9.0, 6.6)

2.0

(− 5.0, 9.0)

Duration of KRT
 ≥ 25 years (ref)
 < 25 years

 − 2.4

(− 17.1, 12.2)

 − 2.1

(− 24.5, 20.2)

 − 8.4

(− 22.8, 5.9)

 − 10.0

(− 23.6, 3.6)

 − 2.4

(− 14.3, 9.5)

 − 4.0

(− 16.1, 8.1)

 − 4.0

(− 24.1, 16.0)

 − 1.4

(− 12.6, 9.7)

 − 3.4

(− 11.7, 4.9)

 − 0.5

(− 8.0, 7.0)

Type of KRT at study
Transplantation (ref)
Dialysis

 − 11.2

(− 28.6, 6.2)

 − 12.4

(− 38.8, 14.1)

 − 8.2

(− 25.5, 9.2)

 − 10.2

(− 26.6, 6.3)

 − 4.4

(− 18.9, 10.0)

 − 4.2

(− 18.8, 10.3)

 − 2.9

(− 26.6, 20.7)

0.2

(− 13.2, 13.5)

 − 7.9

(− 17.5, 1.7)

0.3

(− 8.5, 9.0)

Number of transplants
1 transplant (ref)
 > 1 transplant

 − 6.6

(− 19.6, 6.4)

1.5

(− 18.9, 22.0)

0.6

(− 12.6, 13.9)

7.6

(− 4.8, 20.1)

1.7

(− 9.2, 12.5)

 − 4.7

(− 15.8, 6.3)

 − 8.1

(− 26.3, 10.1)

 − 1.4

(− 11.6, 8.7)

1.5

(− 6.2, 9.1)

 − 1.7

(− 8.6, 5.2)

Abbreviations: CAKUT, congenital anomalies of the kidney and urinary tract; CI, confidence interval; KRT, kidney replacement therapy; ref, reference value

aAdjusted for age and gender

*p value < 0.05

In terms of clinical characteristics, only the type of kidney disease was associated with SF-36 scores. We found that patients with CAKUT and monogenetic hereditary diseases scored significantly higher in the subscale role emotional (28.3, p = 0.011, and 23.2, p = 0.029, respectively) and showed a higher MCS (11.4, p = 0.007, and 9.5, p = 0.018, respectively) compared to patients with acquired kidney diseases. We found no associations between age at first KRT, duration of KRT, type of KRT at time of study, and number of transplants and SF-36 scores.

Discussion

Our study shows that adults who have experienced pediatric KF have a lower physical but similar mental HRQoL compared to the general population. Lower education, unemployment and not being in a relationship were identified as the most important socio-demographic determinants of lower HRQoL. Type of kidney disease was the only clinical factor associated with HRQoL. Patients with acquired kidney diseases reported lower mental HRQoL than patients with CAKUT or monogenetic hereditary diseases.

For a better overview of the results and studies discussed in the following paragraphs, we provided a table in the supplementary material (Online resource 2). Regarding physical HRQoL our study population scored lower in the domains physical functioning, role physical, general health, and in the PCS, than the Swiss general population. A Norwegian study investigating young adults (mean age: 29.8 years) after kidney transplantation during childhood and early adulthood had obtained similar findings. Participants also had lower scores in all predominantly physical subscales of the SF-36, except bodily pain, and for the PCS overall [11]. A Dutch study including participants with a similar mean age (40.6 years) surveyed with the RAND-36 questionnaire, which is almost identical to the SF-36, reported similar results regarding the subscales mainly being associated with physical HRQoL. This population scored lower on the subscales physical functioning and general health, but higher in the subscale bodily pain in comparison to the general population [12]. Collectively, these findings suggest that physical HRQoL is impaired in adults after pediatric KF. This is also reflected in some comments made by our patients in the questionnaire indicating that one of their main daily life problems is physical fatigue.

One study has observed that adults after pediatric KF reported less pain in comparison to the general population [12]. Although not significant, we observed similar findings in our study. One explanation may be that transplanted patients have experienced poor health and strong pain in the past, which may have altered their level of pain tolerance. Additionally, these patients might be more familiar with adequate pain management, as they visit their healthcare provider several times a year.

While adults after pediatric KF in our study scored lower on the subscale vitality, MCS and the other subscales mainly being associated with mental HRQoL did not significantly differ from the Swiss general population. An explanation for the lower vitality score may be the diminished physical health, since vitality is a subscale that also has a notable correlation to the PCS [17]. These reassuring findings regarding mental health are consistent with other studies of adults after pediatric KF [9, 12]. Studies investigating adults after pediatric liver transplantation did not show lower scores for MCS or any other mainly mental SF-36 score when compared to the general population [2123]. Also, a study of adults after heart transplantation during childhood found no difference in mental HRQoL when compared to the general population [24]. These findings suggest that patients requiring transplantation during childhood are mentally resilient, because they successfully cope with the burden of being chronically ill. It has also been speculated that patients with a chronic disease since childhood lack the experience of living without impairment and therefore life meets their expectations [12]. Overall, these studies indicate an excellent outcome regarding mental HRQoL in transplanted children who reached adult age, encouraging and justifying organ transplantation programs during childhood. Patients aged 12–25 on dialysis reported low HRQoL values [25], further indicating that kidney transplantation is the treatment of choice.

Long-term physical and mental HRQoL outcomes in our study population seem to be very similar, or in the case of mental HRQoL even slightly better, compared to those of patients after kidney transplantation during adulthood. A systematic review investigating these patients concluded that physical HRQoL was impaired and mental HRQoL was “lower to comparable” when compared to the general population or healthy controls [26].

Another group of patients where long-term outcome is of great interest are survivors of childhood cancer. The physical and mental HRQoL of Swiss survivors of childhood cancer with a mean age of 25 years were both higher than what was reported in the general population, and the mental HRQoL of survivors was even better than that of their siblings [27]. In contrast to childhood cancer patients, the patients in our study population are not able to go into remission and need life-long immunosuppressive medication and intermittent dialysis treatment. Together with the younger age of the childhood-cancer cohort this may be an explanation for the observed differences.

We did not find associations between age or gender and HRQoL. These findings are in line with past studies with adults with childhood-onset KF [9, 12, 28]. We found that a higher education was associated with better HRQoL. This was also observed in the Swiss general population [16] and among patients with adult-onset KF [29]. Children with mild to moderate chronic kidney disease have been reported to function less well at school [30]. For children with kidney failure, we assume that this is also the case, if not worse, because of frequent hospital appointments for dialysis or follow-up visits after transplantation. Many of our participants left comments that these repeated visits to the hospital affected their performance in school. In Switzerland, there are some schooling programs available in pediatric hospitals, but they are not standardized and largely rely on individual commitments and funding of the hospital. Given that a higher educational achievement is associated with a better HRQoL, such programs could contribute to mitigate adverse outcomes in the long-term.

Our study further indicates that unemployment is a strong predictor of lower HRQoL. This was also found in the Swiss general population [16], patients with adult-onset KF [29] and adults with childhood-onset KF [12]. This is substantiated by free-text feedback from participants, emphasizing that they felt disadvantaged when it came to employment opportunities because of their kidney disease. We also found that participants in a relationship had a higher score in the subscales physical functioning, general health and the PCS. While being in a relationship itself can be invigorating, patients in a relationship may also have a better physical HRQoL because their partner can motivate and support them to be more physically active. It may also be that patients with a better physical health are more likely to find a partner. Overall, it seems that the socio-demographic characteristics such as education, employment status, or relationship status have a stronger correlation to the physical HRQoL than the mental HRQoL. Furthermore, the negative impact of being unemployed or single on HRQoL seems to be greater in the study population than the Swiss general population, especially when comparing the effects on physical HRQoL [16].

Our findings suggest that patients with acquired diseases (n = 16) have a worse mental HRQoL compared to patients with congenital anomalies of the kidney and urinary tract or monogenetic hereditary diseases. Patients with an acquired disease experienced a period in life without being chronically ill. It can only be speculated, whether this explains their impaired mental HRQoL during adulthood. Studies showed that patients with adult-onset KF had a better HRQoL after a kidney transplantation compared to patients on dialysis [26, 31]. In our study we did not find an association between treatment modality at time of study and HRQoL. Comparable findings were described in a previous study investigating adult patients with pediatric KF [12]. An explanation may be that after years of KRT since childhood, adult patients have accepted it as a part of themselves and are less influenced by their type of treatment. In accordance with previous studies, other clinical variables such as age at start of KRT, duration of KRT, or number of transplantations were not associated with HRQoL in adulthood [9, 12, 28].

The main limitation of our study is the relatively small sample size limiting statistical power for subgroup comparisons, especially when comparing modality of treatment at time of study. Although we found no differences when comparing participants and non-participants, our findings might be affected by selection or non-response bias, since patients with a better or worse HRQoL may have been more likely to complete the questionnaire. Additionally, our study lacked information on other potential risk factors for lower HRQoL in chronic kidney disease such as single parent household, anemia, hypertension and mood disorders [32].

In summary, adults after pediatric kidney failure in Switzerland have lower physical, but similar mental HRQoL compared to the general population. This study contributes to increase the awareness about long-term outcomes in adults after pediatric KF and highlights subgroups being at risk of impaired HRQoL during adulthood.

Supplementary Information

Below is the link to the electronic supplementary material.

Acknowledgements

We would like to thank all participants for their cooperation and the Child and Adolescent Health Research Group at the University of Bern for the support of the study

Funding

Open access funding provided by University of Bern

Data availability

The data that support the information of this manuscript were accessed on secured servers of the Institute of Social and Preventive Medicine at the University of Bern. Data can only be made available for researchers who fulfil the respective legal requirements. All data requests should be communicated to the corresponding author.

Declarations

Ethics approval

Ethical approval of the SPRR was granted by the Ethics Committee of the Canton of Bern (140/2015).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Luzius Mader and Guido F. Laube contributed equally to this work (shared last authorship).

References

  • 1.McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350:2654–2662. doi: 10.1056/NEJMoa031643. [DOI] [PubMed] [Google Scholar]
  • 2.Francis A, Johnson DW, Melk A, Foster BJ, Blazek K, Craig JC, Wong G. Survival after kidney transplantation during childhood and adolescence. Clin J Am Soc Nephrol. 2020;15:392–400. doi: 10.2215/CJN.07070619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Groothoff JW, Offringa M, Grootenhuis M, Jager KJ. Long-term consequences of renal insufficiency in children: lessons learned from the Dutch LERIC study. Nephrol Dial Transplant. 2018;33:552–560. doi: 10.1093/ndt/gfx190. [DOI] [PubMed] [Google Scholar]
  • 4.Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Kidney Int. 2003;64:339–349. doi: 10.1046/j.1523-1755.2003.00072.x. [DOI] [PubMed] [Google Scholar]
  • 5.Falger J, Landolt MA, Latal B, Ruth EM, Neuhaus TJ, Laube GF. Outcome after renal transplantation. Part II: quality of life and psychosocial adjustment. Pediatr Nephrol. 2008;23:1347–1354. doi: 10.1007/s00467-008-0798-x. [DOI] [PubMed] [Google Scholar]
  • 6.Bartosh SM, Leverson G, Robillard D, Sollinger HW. Long-term outcomes in pediatric renal transplant recipients who survive into adulthood. Transplantation. 2003;76:1195–1200. doi: 10.1097/01.TP.0000092524.75807.84. [DOI] [PubMed] [Google Scholar]
  • 7.Morel P, Almond PS, Matas AJ, Gillingham KJ, Chau C, Brown A, Kashtan CE, Mauer SM, Chavers B, Nevins TE, et al. Long-term quality of life after kidney transplantation in childhood. Transplantation. 1991;52:47–53. doi: 10.1097/00007890-199107000-00010. [DOI] [PubMed] [Google Scholar]
  • 8.Kärrfelt HM, Berg UB. Long-term psychosocial outcome after renal transplantation during childhood. Pediatr Transplant. 2008;12:557–562. doi: 10.1111/j.1399-3046.2007.00859.x. [DOI] [PubMed] [Google Scholar]
  • 9.Groothoff JW, Grootenhuis MA, Offringa M, Gruppen MP, Korevaar JC, Heymans HS. Quality of life in adults with end-stage renal disease since childhood is only partially impaired. Nephrol Dial Transplant. 2003;18:310–317. doi: 10.1093/ndt/18.2.310. [DOI] [PubMed] [Google Scholar]
  • 10.Haavisto A, Jalanko H, Sintonen H, Holmberg C, Qvist E. Quality of life in adult survivors of pediatric kidney transplantation. Transplantation. 2011;92:1322–1326. doi: 10.1097/TP.0b013e318237062b. [DOI] [PubMed] [Google Scholar]
  • 11.Aasebø W, Homb-Vesteraas NA, Hartmann A, Stavem K. Life situation and quality of life in young adult kidney transplant recipients. Nephrol Dial Transplant. 2009;24:304–308. doi: 10.1093/ndt/gfn537. [DOI] [PubMed] [Google Scholar]
  • 12.Tjaden LA, Vogelzang J, Jager KJ, van Stralen KJ, Maurice-Stam H, Grootenhuis MA, Groothoff JW. Long-term quality of life and social outcome of childhood end-stage renal disease. J Pediatr. 2014;165(336–342):e331. doi: 10.1016/j.jpeds.2014.04.013. [DOI] [PubMed] [Google Scholar]
  • 13.Maurer E, Neuhaus TJ, Weitz M, Kuehni CE, Laube GF. Paediatric end-stage renal disease and renal replacement therapy in Switzerland: survival and treatment trends over four decades. Swiss Med Wkly. 2020;150:w20300. doi: 10.4414/smw.2020.20300. [DOI] [PubMed] [Google Scholar]
  • 14.Kuehni CE, Rueegg CS, Michel G, Rebholz CE, Strippoli MP, Niggli FK, Egger M, von der Weid NX. Cohort profile: the Swiss childhood cancer survivor study. Int J Epidemiol. 2012;41:1553–1564. doi: 10.1093/ije/dyr142. [DOI] [PubMed] [Google Scholar]
  • 15.Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute; 1993. [Google Scholar]
  • 16.Roser K, Mader L, Baenziger J, Sommer G, Kuehni CE, Michel G. Health-related quality of life in Switzerland: normative data for the SF-36v2 questionnaire. Qual Life Res. 2019;28:1963–1977. doi: 10.1007/s11136-019-02161-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ware JE, Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998;51:903–912. doi: 10.1016/s0895-4356(98)00081-x. [DOI] [PubMed] [Google Scholar]
  • 18.Ware JE, Kosinski M, Keller SD. SF-36 Physical and mental health summary scales: a user’s manual. Boston, MA: Health Assessment Lab; 1994. [Google Scholar]
  • 19.Maruish ME (2011) User’s manual for the SF36v2 Health Survey. QualityMetric Incorporated, Lincoln, RI.
  • 20.Kuehni CE, Strippoli MP, Rueegg CS, Rebholz CE, Bergstraesser E, Grotzer M, von der Weid NX, Michel G. Educational achievement in Swiss childhood cancer survivors compared with the general population. Cancer. 2012;118:1439–1449. doi: 10.1002/cncr.26418. [DOI] [PubMed] [Google Scholar]
  • 21.Mohammad S, Hormaza L, Neighbors K, Boone P, Tierney M, Azzam RK, Butt Z, Alonso EM. Health status in young adults two decades after pediatric liver transplantation. Am J Transplant. 2012;12:1486–1495. doi: 10.1111/j.1600-6143.2012.04080.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Konidis SV, Hrycko A, Nightingale S, Renner E, Lilly L, Therapondos G, Fu A, Avitzur Y, Ng VL. Health-related quality of life in long-term survivors of paediatric liver transplantation. Paediatr Child Health. 2015;20:189–194. doi: 10.1093/pch/20.4.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kosola S, Lampela H, Lauronen J, Makisalo H, Jalanko H, Qvist E, Pakarinen MP. General health, health-related quality of life and sexual health after pediatric liver transplantation: a nationwide study. Am J Transplant. 2012;12:420–427. doi: 10.1111/j.1600-6143.2011.03819.x. [DOI] [PubMed] [Google Scholar]
  • 24.Petroski RA, Grady KL, Rodgers S, Backer CL, Kulikowska A, Canter C, Pahl E. Quality of life in adult survivors greater than 10 years after pediatric heart transplantation. J Heart Lung Transplant. 2009;28:661–666. doi: 10.1016/j.healun.2009.04.004. [DOI] [PubMed] [Google Scholar]
  • 25.Tong A, Wong G, McTaggart S, Henning P, Mackie F, Carroll RP, Howard K, Craig JC. Quality of life of young adults and adolescents with chronic kidney disease. J Pediatr. 2013;163(1179–1185):e1175. doi: 10.1016/j.jpeds.2013.04.066. [DOI] [PubMed] [Google Scholar]
  • 26.Wang Y, Hemmelder MH, Bos WJW, Snoep JD, de Vries APJ, Dekker FW, Meuleman Y. Mapping health-related quality of life after kidney transplantation by group comparisons: a systematic review. Nephrol Dial Transplant. 2021;36:2327–2339. doi: 10.1093/ndt/gfab232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Rueegg CS, Gianinazzi ME, Rischewski J, Beck Popovic M, von der Weid NX, Michel G, Kuehni CE. Health-related quality of life in survivors of childhood cancer: the role of chronic health problems. J Cancer Surviv. 2013;7:511–522. doi: 10.1007/s11764-013-0288-4. [DOI] [PubMed] [Google Scholar]
  • 28.Tozzi AE, Mazzotti E, Di Ciommo VM, Dello Strologo L, Cuttini M. Quality of life in a cohort of patients diagnosed with renal failure in childhood and who received renal transplant. Pediatr Transplant. 2012;16:840–845. doi: 10.1111/j.1399-3046.2012.01774.x. [DOI] [PubMed] [Google Scholar]
  • 29.Gentile S, Beauger D, Speyer E, Jouve E, Dussol B, Jacquelinet C, Briancon S. Factors associated with health-related quality of life in renal transplant recipients: results of a national survey in France. Health Qual Life Outcomes. 2013;11:88. doi: 10.1186/1477-7525-11-88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gerson AC, Wentz A, Abraham AG, Mendley SR, Hooper SR, Butler RW, Gipson DS, Lande MB, Shinnar S, Moxey-Mims MM, Warady BA, Furth SL. Health-related quality of life of children with mild to moderate chronic kidney disease. Pediatrics. 2010;125:e349–357. doi: 10.1542/peds.2009-0085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Liem YS, Bosch JL, Arends LR, Heijenbrok-Kal MH, Hunink MG. Quality of life assessed with the Medical Outcomes Study Short Form 36-Item Health Survey of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2007;10:390–397. doi: 10.1111/j.1524-4733.2007.00193.x. [DOI] [PubMed] [Google Scholar]
  • 32.Soni RK, Weisbord SD, Unruh ML. Health-related quality of life outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens. 2010;19:153–159. doi: 10.1097/MNH.0b013e328335f939. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The data that support the information of this manuscript were accessed on secured servers of the Institute of Social and Preventive Medicine at the University of Bern. Data can only be made available for researchers who fulfil the respective legal requirements. All data requests should be communicated to the corresponding author.


Articles from Pediatric Nephrology (Berlin, Germany) are provided here courtesy of Springer

RESOURCES